Literature DB >> 20522677

Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.

Rose McGready1.   

Abstract

Entities:  

Year:  2010        PMID： 20522677     DOI： 10.1136/ebm1039

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  1 in total

1.  Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.

Authors:  Erin Milner; Jason Sousa; Brandon Pybus; Victor Melendez; Sean Gardner; Kristina Grauer; Jay Moon; Dustin Carroll; Jennifer Auschwitz; Montip Gettayacamin; Patricia Lee; Susan Leed; William McCalmont; Suzanne Norval; Anchalee Tungtaeng; Qiang Zeng; Michael Kozar; Kevin D Read; Qigui Li; Geoffrey Dow
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-13       Impact factor: 2.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.